The Clatterbridge Cancer Centre (CCC) has long recognised the importance of patient and public participation in routine and research activities. Patients are invited to participate in clinical trials.
In 2014, NHS England published its Five Year Forward View which proposed a more engaged relationship with patients and carers. For compliance, our directorate of Research & Innovation has sought to extend patients’ involvement in its activities.
In 2019-2020, CCC launched a comprehensive Patient Involvement Strategy to ensure that our care and services take into account patient and public experience.
In addition, CCC is committed to involving diverse socio-economic groups of patients and public in its research activities. Such involvement provides a wealth of insight, perspectives, expertise and experience.
In November 2020, our newly established Patient and Public Involvement Forum convened for the first time. It meets on a regular basis and, in November 2021, a newsletter from the Forum was launched.
Emma Whitby, Head of Research Delivery, said: “I’m delighted with the formation of the PPI group. Patients are at the heart of what we do and ensuring they have a voice that is heard is of paramount importance to staff in R&I.”
For more information about the Forum or to ask to join it, please email emma.whitby1@nhs.net
CCC is a partner in a Biomedical Research Centre (BRC) with The Royal Marsden Hospital and The Institute of Cancer Research, in London. The BRC has a Patients' Voice website with information about patient and public involvement in its work. You can access this here: Cancer Patients' Voice (cancerbrc.org)
You can read the CCC R&I PPI Forum newsletter below.
Research Matters Newsletter, Winter 2023-24
Previous editions:
